MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.

Employees

Sector

Drug Retailers

More about the company

Real-time Euronext Paris 01:30:11 24/10/19 am AEDT			5-day change	1st Jan Change
20.20 ^EUR	-.--%		-.--%	+18.82%

10/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI

Market Cap	38.47M 33.88M 32.1M 28.98M 54.61M 3.69B 55.32M 384M 148M 1.89B 144M 141M 6.05B	P/E 2017	17.4x	P/E 2018	19.8x
Enterprise Value	36.72M 32.33M 30.63M 27.66M 52.12M 3.52B 52.8M 367M 141M 1.8B 138M 135M 5.77B	EV / Sales 2017	1.97x	EV / Sales 2018	1.38x
Free-Float	5.42%	Yield 2017	3.36%	Yield 2018	-

10/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI
18/09/19	Curae Lab SARL agreed to acquire remaining 12.5% stake in Millet Innovation SA from Holding Managers for €4.8 million.	CI

26/10/19	Millet Innovation : MILLET INNOVATION - MISE EN OEUVRE DU RETRAIT OBLIGATOIRE
09/10/19	Millet Innovation : Communiqué de mise à disposition des Autres informations
09/10/19	Millet Innovation : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE D’INFORMATION ETABLI PAR CURAE LAB
18/09/19	Millet Innovation : DEPOT PROJET DE NOTE D’INFORMATION EN REPONSE RELATIVE A L’OPAS
18/09/19	Millet Innovation : RAPPORT SEMESTRIEL AU 30/06/2019

Millet Innovation Stock

Stocks

ALINN

FR0010304402

Drug Retailers

Valuation: Millet Innovation

Latest news: Millet Innovation

News in other languages: Millet Innovation

Managers and Directors: Millet Innovation

Retail - Drugs without Grocery

Financials

Company Profile

Manager	Title	Age	Since
Damien Millet CEO	Chief Executive Officer	-	09/12/2002
Valérie Chopinet DFI	Director of Finance/CFO	-	19/12/2006

Director	Title	Age	Since
Jean-Claude Millet CHM	Chairman	-	16/03/1998
Pierre Martin BRD	Director/Board Member	-	16/03/1998
Jean-Paul Maingaud BRD	Director/Board Member	-	31/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MILLET INNOVATION	-.--%	-.--%	-	-	42.79M
JD HEALTH INTERNATIONAL INC.	-0.11%	+0.06%	-45.86%	-11.33%	14.63B
TSURUHA HOLDINGS INC.	-0.95%	-3.21%	-10.12%	+3.87%	6.1B
RAIA DROGASIL S.A.	+1.27%	-5.79%	+1.72%	-32.16%	6.2B
MATSUKIYOCOCOKARA & CO.	+0.51%	-3.03%	-17.95%	-6.67%	6.1B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+1.42%	+1.06%	-56.98%	-41.29%	5.9B
YIFENG PHARMACY CHAIN CO., LTD.	+1.30%	+5.52%	-5.44%	-20.24%	4.21B
NAHDI MEDICAL COMPANY	+0.11%	-0.38%	-26.71%	-37.86%	3.15B
COSMOS PHARMACEUTICAL CORPORATION	+0.94%	-3.24%	-27.08%	-17.65%	3.1B
CLICKS GROUP LIMITED	-2.34%	-1.42%	-40.70%	-19.20%	2.98B
Average	+0.21%	-1.55%	-25.46%	-20.28%	5.24B
Weighted average by Cap.	+0.26%	-1.67%	-28.26%	-17.99%

	2017	2018
Net sales	21.86M 19.25M 18.24M 16.46M 31.03M 2.1B 31.43M 218M 83.97M 1.07B 82.08M 80.29M 3.44B	22.21M 19.56M 18.53M 16.73M 31.53M 2.13B 31.94M 222M 85.32M 1.09B 83.4M 81.58M 3.49B
Net income	2.54M 2.24M 2.12M 1.92M 3.61M 244M 3.66M 25.38M 9.77M 125M 9.55M 9.34M 400M	1.63M 1.44M 1.36M 1.23M 2.32M 157M 2.35M 16.3M 6.27M 80.02M 6.13M 6M 257M
Net Debt	-1.07M -938K -889K -803K -1.51M -102M -1.53M -10.64M -4.09M -52.24M -4M -3.91M -167M	-1.75M -1.54M -1.46M -1.32M -2.49M -168M -2.52M -17.49M -6.73M -85.89M -6.58M -6.44M -275M